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Abstract. To study the immune-inflammatory response 
and signaling mechanism of macrophages to purified 
Enterococcus faecalis (E. faecalis) lipoteichoic acid (LTA), 
intact LTA was obtained from an E. faecalis clinical strain 
P25RC using the butanol method and hydrophobic interaction 
chromatography purification. The fractions containing LTA 
were determined using phosphate detection. Contaminations 
with lipopolysaccharide and proteins were excluded using 
the Limulus amoebocyte lysate assay and sodium dodecyl 
sulfate‑polyacrylamide gel electrophoresis, respectively. LTA 
was analyzed using nuclear magnetic resonance. Prior to LTA 
stimulation assays, THP-1 monocytes were pretreated with 
phorbol 12-myristate 13-acetate to differentiate into macro-
phages. Macrophages were treated with LTA in concentration 
gradients and cells without LTA treatment as the control. 
Gene expression of TLR2, CD14 and MyD88 were evaluated 
by quantitative polymerase chain reaction. Tumor necrosis 
factor-α (TNF-α) and interleukin (IL)‑10 were quantified using 
ELISA. The activated and total nuclear factor‑κB (NF-κB) p65 
and three mitogen-activated protein kinases (p38, ERK1/2 and 
JNK) were assessed using western blot analysis. E. faecalis 
LTA induced the gene expression of TLR2 and MyD88 whilst 
it downregulated CD14, suggesting a TLR2-dependent and 
CD14‑independent immune‑inflammatory activity. LTA stim-
ulated the expression of pro‑inflammatory cytokine TNF‑α 
(P<0.05), but not the anti‑inflammatory cytokine IL‑10. In 
conclusion, E. faecalis LTA stimulated the expression of 
TNF-α in macrophages possibly through the NF-κB and p38 
pathways.
Introduction
Enterococcus faecalis (E. faecalis), a Gram-positive 
bacterium, is a predominant cause of hospital-associated 
infections (1). E. faecalis is also involved in root canal infec-
tions (2) and is considered a major pathogen associated with 
endodontic treatment failure (3). Several virulence attributes 
that promote bacterial colonization, the invasion of host tissues 
and the evasion of host defense mechanisms are indicated in 
persistent infections caused by E. faecalis (4). The virulence 
factors include lipoteichoic acid (LTA), peptidoglycan, 
aggregation substances, cytolysin and lytic enzymes. Among 
them, LTA is the key virulence factor due to its major role in 
pathogenicity. It has been demonstrated that E. faecalis LTA 
can stimulate leukocytes to release certain mediators associ-
ated with inflammatory response (5) and plays a critical role 
in biofilm formation (6). E. faecalis LTA is also known to 
inhibit the repair mechanism of periapical bone by decreasing 
the proliferation of human osteoblast-like cells and inducing 
apoptosis (7).
E. faecalis LTA belongs to classical (type 1) LTA. Its basic 
structure is comprised of a glycolipid moiety and 1,3-polyg-
lycerolphosphate substituted at position C-2 with D-alanine 
and kojibiose residues (8). The alanyl esters with D‑configured 
glycerophosphate influence the antibiotic action, pathogenesis, 
adhesion, biofilm formation and virulence of Gram‑positive 
bacteria (6,9). The dlt operon consists of 4 genes: dltA, 
dltB, dltC and dltD, which are responsible for D-alanine 
synthesis (10). The inactivation of the dlt genes resulted in the 
absence of D-alanyl residues of LTA and further decreased the 
virulence features of E. faecalis (6).
Bacterial antigens are recognized by the pattern recognition 
receptors (PRRs) of immune cells and subsequently induce the 
production of pro‑inflammatory cytokines. Toll‑like receptors 
(TLR) are ubiquitous PRRs that play a pivotal role in the 
innate immune response (11). Of all the TLRs, TLR2 is known 
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to specifically interact with bacterial LTA (12). Baik et al (5) 
found that E. faecalis LTA stimulates RAW 264.7 cells to 
express tumor necrosis factor-α (TNF-α). However, molecular 
mechanisms pertaining to the sensing and signaling of clini-
cally derived E. faecalis LTA and human macrophages have not 
yet been studied. The cells of the THP‑1 human monocytic cell 
line can differentiate into macrophages under stimulation by 
phorbol 12‑myristate 13‑acetate (PMA) (13). The differentiated 
THP-1 macrophages are widely used as human macrophages 
in vitro for studying inflammatory diseases (14,15). In order 
to address this research gap, highly purified, intact LTA was 
extracted from an E. faecalis clinical strain and its effect on 
TNF-α production was studied in differentiated THP-1 macro-
phages. Nuclear factor‑κB (NF-κB) and p38 mitogen-activated 
protein kinase (MAPK) signaling pathways are activated by 
endodontic infectious contents (16). The present study also 
investigated the involvement of NF-κB and MAPK signaling 
pathways in the production of TNF-α.
Materials and methods
Bacteria and cell culture. E. faecalis P25RC was isolated 
from a patient's root canal at the Peking University Hospital 
of Stomatology (Beijing, China) by Zhu et al (17). E. faecalis 
P25RC was grown anaerobically (90% N2, 5% CO2 and 5% H2) 
overnight at 37˚C without agitation in the brain‑heart infusion 
broth (Oxoid Ltd., Basingstoke, Hampshire, UK). Once the 
bacterial growth reached the mid-exponential phase (A600=0.5), 
10 liters of the bacteria were harvested by centrifugation and 
washed twice with phosphate‑buffered saline (PBS; pH 7.4) 
(Sigma‑Aldrich, St. Louis, MO, USA). The bacteria were 
examined by Gram staining and microscopy to rule out contam-
inations. The bacteria were stored at ‑70˚C until LTA extraction.
THP-1 cells (ATCC® TIB-202™) were purchased from 
American Type Culture Collection (ATCC, Manassas, VA, 
USA). THP‑1 cells were maintained in RPMI‑1640 medium 
(Life Technologies, Grand Island, NY, USA) supplemented 
with 10% heat-inactivated fetal bovine serum (HyClone, 
Logan, UT, USA), 50 µM 2-mercaptoethanol (Sigma-Aldrich), 
100 IU/ml penicillin and 100 µg/ml streptomycin (Invitrogen 
Life Technologies, Carlsbad, CA, USA). The cells were incu-
bated at 37˚C with 5% CO2. The experiments were performed 
in 6-well plates at a density of 8x105 cells/ml. Before the LTA 
stimulation assays, THP-1 monocytes were pretreated with 
200 ng/ml PMA (Sigma-Aldrich) for 18 h to differentiate them 
into macrophages, which facilitates the adhesion of the cells (18).
Isolation and purification of LTA. The processes of isola-
tion and purification of LTA were performed as described 
previously (19). The bacteria were defrosted and suspended 
in 100 ml of 0.1 M cold sodium citrate buffer (pH 4.7) 
(Sigma‑Aldrich). Following disruption by Vibra‑Cell ultra-
sonication (Sonic and Materials, Inc., Danbury, CT, USA) at 
40% amplitude in pulse mode of 5-sec on and 5-sec off for 
30 min on ice, the cell lysate was stirred with 100 ml n-butanol 
(Sigma‑Aldrich) at 4˚C for 30 min. Subsequently, centrifuga-
tion was carried out at 7,000 x g for 45 min. The lower aqueous 
phase was collected and 100 ml sodium citrate buffer was 
added again for re‑extraction. The two aqueous phases were 
pooled and dialyzed overnight in deionized water using a 
dialysis membrane with MWCO 1000 (Spectrum Laboratories 
Inc., Rancho Dominguez, CA, USA). The dialyzed sample 
was treated with vacuum filtration (Millipore, Billerica, MA, 
USA) and prepared for purification. The dialyzed sample was 
subjected to hydrophobic interaction chromatography (HIC) 
on an octyl‑sepharose column (2.5x10 cm) (Sigma‑Aldrich). 
The dialyzed sample was prepared and transferred to HIC in 
15% n‑propanol in 0.1 M ammonium acetate. The bond frac-
tions were eluted with a linear concentration gradient from 15 
to 60% n‑propanol in 0.1 M ammonium acetate (pH 4.7).
The structure of the LTA was assayed by 1H nuclear 
magnetic resonance (NMR) spectrometry as described previ-
ously (19). The purity of the LTA was determined by measuring 
the protein content through Coomassie Blue G-250 staining 
(Bio-Rad, Hercules, CA, USA) following sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 
gradient gels containing 5-12% wt/vol acrylamide (Bio‑Rad). 
Precision Plus Protein Unstained standards (Bio-Rad) were 
used as reference markers. The molecular weight of LTA was 
shown in the SDS-PAGE gel stained with Coomassie Blue 
dye. Endotoxin contamination was excluded using a Limulus 
amoebocyte lysate (LAL) assay kit (Pierce, Rockford, IL, 
USA) according to the manufacturer's instructions. Thus, 
the endotoxin was quantified and the contamination was 
evaluated (19,20). DNA or RNA contamination was deter-
mined by measuring ultraviolet (UV) absorption at 260 and 
280 nm (NanoDrop Spectrophotometer 2000; Thermo Fisher 
Scientific, Wilmington, DE, USA) (21).
Extraction of the E. faecalis genome and detection of dlt 
genes. The genome of E. faecalis P25RC was extracted using 
the Wizard Genome DNA Purification kit (Promega Corp., 
Madison, WI, USA). The fragments of genes dltA and dltB 
were amplified using polymerase chain reaction (PCR). The 
sequences of primers were: dltA forward, 5'-TTGATGAAT 
GGGCACGTAAA-3' and reverse, 5'-GCCAATGCGGGA 
TAAATAGA-3'; and dltB forward, 5'-AGGTGAATGCCA 
CATGA-3' and reverse, 5'-GACACCACCAAGATAATGACT
GA-3' (6). The PCR products were visualized on a 1.5% 
agarose gel stained with Redsafe Nucleic Acid Staining 
Solution (1:10,000) (iNtRON, Seoul, Korea).
LTA treatment. LTA-containing fractions were pooled and 
lyophilized. LTA was weighed using an analytical balance 
(Sartorious, Goettingen, Germany), reconstituted using PBS 
(pH 7.4) to a concentration of 1 mg/ml and stored at ‑70˚C 
until use. E. faecalis LTA was added into RPMI-1640 
culture medium and mixed thoroughly in plastic tubes. PMA 
pre-activated THP-1 cells were treated with E. faecalis LTA at 
a gradient concentration between 0.1 and 50 µg/ml at 37˚C for 
18 h. Cells without LTA treatment were used as controls. All 
the experiments were performed in triplicate.
ELISA assays. Following the stimulation of the cells with 
E. faecalis LTA, supernatants were collected and assayed for 
inflammatory and anti‑inflammatory cytokines using sand-
wich ELISA with their well‑matched antibodies. Cytokines, 
such as TNF-α and interleukin (IL)-10, were detected using 
ELISA kits (Invitrogen Life Technologies, Frederick, MD, 
USA) according to the manufacturer's instructions (22).
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Quantitative PCR (qPCR). The cells were washed twice with 
PBS and harvested by scraping using cell scrapers (Costar, 
Corning, NY, USA) following incubation with LTA. The 
mRNA of each sample was extracted and purified using the 
RNeasy Plus Mini kit (Qiagen, Hilden, Germany) and quanti-
fied using a Nanodrop 2000 spectrophotometer (Thermo Fisher 
Scientific). The cDNA was obtained through SuperScript® 
VILO™ MasterMix (Invitrogen Life Technologies) using 
1.5 µg mRNA as a template for the final reaction volume of 
20 µl. The qPCR was performed using a StepOne qPCR System 
(Applied Biosystems Inc., Carlsbad, CA, USA) in standard 
mode and the PCR products were detected with SYBR-Green 
(Life Technologies, Austin, TX, USA). The signaling pathway 
messengers, including TLR2, CD14 and MyD88, were ampli-
fied using qPCR. Primer sequences were as follows: TLR2 
forward, 5'-TTATCCAGCACACGAATACACAG-3' and 
reverse, 5'-AGGCATCTGGTAGAGTCATCAA-3'; CD14 
forward, 5'-GACCTAAAGATAACCGGCACC-3' and reverse, 
5'-GCAATGCTCAGTACCTTGAGG-3'; MyD88 forward, 
5'-GGCTGCTCTCAACATGCGA-3' and reverse, 5'-CTG 
TGTCCGCACGTTCAAGA-3'; and GAPDH forward, 
5'-ATGTGTCCGTCGTGGATCTGA-3' and reverse, 5'-ATG 
CCTGCTTCACCACCTTCT‑3'. The qPCR reaction conditions 
were performed at 95˚C for 10 min, followed by 40 cycles of 
95˚C for 15 sec and 60˚C for 1 min. The experiment was 
performed in triplicate. The relative expression of the mRNA 
was normalized with GAPDH using the 2‑ΔΔCT method.
Western blot analysis. The phosphorylation of NF-κB and 
MAPKs, including ERK1/2, JNK1/2 and p38, was detected by 
western blot analysis, as previously described (21). The nuclear 
and cytoplasmic proteins were extracted using NE-PER™ 
Nuclear and Cytoplasmic Extraction reagents (Thermo Fisher 
Scientific, Rockford, IL, USA). The protein was quantified with 
a BCA™ protein assay kit (Thermo Fisher Scientific). Briefly, 
cell lysates containing 20 µg of protein were boiled for 5 min 
in Lane Marker Sample buffers (Thermo Fisher Scientific) and 
the volume ratio of sample buffer in the protein sample was 1:4. 
The protein was subsequently separated by 5-12% SDS-PAGE 
(Bio‑Rad) and blotted onto polyvinylidene fluoride membranes 
(GE Healthcare, Uppsala, Sweden). After blocking for 1 h in 
20 mmol/l Tris-HCl, 150 mmol/l NaCl and 0.05% Tween‑20 
(TBS-T) containing 5% skimmed milk, the membranes were 
washed three times in 20 ml TBS-T and probed overnight at 
4°C with rabbit anti-human antibodies for phospho-NF-κB 
p65 (monoclonal; 3033), NF-κB p65 (monclonal; 4764), 
phospho-p38 (polyclonal; 9211), p38 (polyclonal; 9212), 
phospho ERK1/2 (monoclonal; 4377), ERK1/2 (monoclonal; 
4695), phospho-SAPK/JNK (monoclonal; 4671), SAPK/JNK 
(polyclonal; 9252) (Cell Signaling, Beverly, MA, USA) in 
TBS‑T with 0.5% skimmed milk. Following three washes in 
20 ml TBS-T, the membranes were incubated with secondary 
horseradish peroxidase (HRP)-conjugated anti-rabbit antibody 
(Cell Signaling Technology, Inc., Beverly, MA, USA) for 2 h 
and washed three times in 20 ml TBS‑T. Bands were detected 
using enhanced chemiluminescence reagents (Thermo Fisher 
Scientific, Wilmington, DE, USA). The proteins were normal-
ized with β‑actin (Santa Cruz Biotechnology Inc., Dallas, 
TX, USA). The band densities were measured using Quantity 
One 4.6.9 software (Bio‑Rad).
Statistical analysis. The qPCR, ELISA and western blot 
analysis data were analyzed by analysis of variance using 
IBM SPSS software version 20 (IBM Corp., Armonk, NY, 
USA). The Bonferroni method was used to compare the differ-
ence between two groups. P<0.05 was considered to indicate a 
statistically significant difference.
Results
Extraction, purification and identification of LTA. E. faecalis 
P25RC was grown and reached an optical density of 0.5 at 
600 nm for LTA extraction (Fig. 1A). LTA was extracted using 
the n‑butanol method and purified by HIC on octyl‑sepharose. 
The bond fractions were assayed for total phosphorus 
(Fig. 1B). The fractions corresponding to the peak on the 
curve, which were considered the ones containing LTA, were 
Figure 1. Determination of lipoteichoic acid (LTA). (A) The growth kinetic 
curve of Enterococcus faecalis (E. faecalis) P25RC at an optical density (OD) 
at 600 nm. (B) Phosphate detection at an OD at 620 nm. The black arrow 
points to the fractions containing highly purified LTA. (C) The 1H-nuclear 
magnetic resonance spectrum of LTA from E. faecalis P25RC (600 MHz). 
(D) The image of SDS‑PAGE. The molecular weight of LTA is ~20 kDa. 
Lane 1, protein ladder; lane 2, LTA (5 µg); lane 3, LTA (10 µg). (E) The image 
of the dltA and dltB gene fragments on the agarose gel. Lane 1, DNA ladder; 
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pooled. The structure of LTA was detected using 1H NMR 
spectrometry (Fig. 1C). The purity of LTA was determined 
by measuring the protein contamination through Coomassie 
Blue staining following SDS-PAGE and the molecular weight 
of LTA showed ~20 kDa (Fig. 1D). Endotoxin contamination 
was excluded through an LAL assay and endotoxin content 
was <0.3 EU/mg in the lyophilized LTA. DNA and RNA 
contaminations were determined by measuring UV absorption 
at 260 and 280 nm. DNA and RNA accounted for 5.4 and 3.4% 
(wt/wt), respectively. Conclusively, purified LTA was prepared. 
The D‑alanine residue was confirmed by amplifying the frag-
ments of the dltA and dltB operon genes using PCR (Fig. 1E). 
The presence of PCR products on the agarose gel showed the 
dltA (598 bp) and dltB (649 bp) fragments. Preliminarily, LTA 
from E. faecalis P25RC could be confirmed as D‑alanyl LTA.
LTA promotes the gene expression of TLR2 and MyD88. 
LTA from the E. faecalis P25RC clinical strain was used to 
treat macrophages that were differentiated from THP‑1 cells. 
Cells without LTA treatment were used as controls. At the 
concentration of 50 µg/ml LTA, the expression of TLR2 was 
enhanced ≤1.4‑fold compared to the control and additionally, 
the expression of MyD88 was enhanced ≤1.4‑fold compared 
to 0.1 and 1 µg/ml LTA treatment. The expression of CD14 
was decreased by 0.5‑fold compared to the control. Based on 
the results of qPCR, D-alanyl LTA from E. faecalis P25RC 
promoted the gene expression of TLR2 (P<0.05, Fig. 2A) and 
MyD88 (P<0.05, Fig. 2B), but LTA downregulated CD14 
(P<0.05, Fig. 2C). In particular, LTA from E. faecalis P25RC 
induced an inflammatory response through TLR2-dependent 
and CD14‑independent signaling transduction.
LTA promotes the expression of TNF‑α. The cytokines, such 
as TNF-α and IL-10, were detected using ELISA sandwich 
kits. LTA stimulated the expression of pro‑inflammatory cyto-
kine TNF-α (P<0.05, Fig. 3A), but not the anti‑inflammatory 
cytokine IL‑10 (P>0.05, Fig. 3B).
LTA promotes p38 and NF‑κB signaling pathways. The three 
activated total MAPKs (p38, ERK1/2 and JNK) (Fig. 3C) 
and NF-κB p65 (Fig. 3D) were assayed using western blot 
analysis. In the present study, the results also suggest that 
MAPKs, particularly p38, may play an important role in signal 
transduction for TNF-α production. There was a dose‑depen-
dent increase in p‑p38 (P<0.05, Fig. 3E) and p‑NF‑κB activity 
(P<0.05 compared to the control, Fig. 3I). By contrast, 
E. faecalis LTA did not induce ERK1/2 or JNK activity. The 
total ERK1/2 (Fig. 3G) and JNK (Fig. 3H) were upregulated, 
but the activation was not detected. Therefore, the p‑p38 and 
p-NF-κB signaling transduction pathways likely play a major 
role in E. faecalis LTA-induced TNF-α expression in differen-
tiated THP‑1 macrophages.
Discussion
The present study examined the molecular mechanism behind 
the interaction of a highly purified LTA derived from the 
E.  faecalis clinical strain with differentiated THP-1 macro-
phages. The n-butanol method and HIC on octyl-sepharose 
were used to extract and purify LTA. The butanol method can 
be used to extract structurally intact LTA and has been widely 
used to extract LTA from numerous types of Gram-positive 
bacteria, such as Staphylococcus aureus, Streptococcus pneu‑
moniae, E. faecalis and Streptococcus gordonii (6,19,23,24). 
Furthermore, SDS-PAGE and Coomassie Blue G-250 staining 
were used to detect protein contamination. Coomassie Blue 
G-250 staining provides a detection limit of 1 ng protein 
and is sensitive enough to exclude protein contamination. Of 
note, LTA could be exhibited on the gel following staining 
by Coomassie Blue, while LTA was previously examined 
using silver stain (25,26). LTA showed a clear broad band of 
~20 kDa. The LTA image was in agreement with a previous 
study regarding LTA derived from other Gram-positive 
bacteria (27). Therefore, SDS‑PAGE analysis with Coomassie 
Blue staining could become a rapid and easy way to detect 
LTA. The NMR spectrum was highly analogous to those 
reported in a previous study regarding E. faecalis LTA (6). 
Taken together, highly purified LTA was successfully isolated 
from an E. faecalis clinical strain.
LTA is an amphiphile that is anchored to the cell membrane 
via its glycolipid and extends its long chains of glycerophos-
phate into the wall (20). The dlt genes are involved in the 
production of D-alanine residues and the inactivation of the 
dlt genes can lead to the absence of D-alanine linked on the 
LTA glycerolphosphate backbone. Furthermore, D‑alanine 
is closely associated with the formation of biofilm (9). 
Figure 2. Relative mRNA expression of signaling mediators, including (A) TLR2, (B) MyD88 and (C) CD14, was assayed using quantitative polymerase chain 
reaction. Data are presented as mean ± standard deviation. *P<0.05 compared to the untreated cells. LTA, lipoteichoic acid.
  A   B   C
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Fabretti et al (6) found that the dltA deletion mutant of a strong 
biofilm producer (E. faecalis 12030) was not as potent as the 
wild‑type strain in the production of biofilm. In the present 
study, the dltA and dltB genes were detected in E. faecalis 
P25RC. They are responsible for the production of D-alanine, 
suggesting that E. faecalis P25RC LTA contains D‑alanine. 
The E. faecalis P25RC strain came from an infected root canal 
of a patient suffering from persistent periapical periodontitis. 
Therefore, understanding the immune‑inflammatory activity 
of E. faecalis P25RC may enhance our understanding of the 
apical resorption process observed in endodontic infections.
As a surface molecule of Gram-positive bacteria, LTA plays 
an important role in the stimulation of inflammatory responses, 
in vivo and in vitro (21,28). In the present study, gene expres-
sion of the signaling mediators was detected using qPCR. LTA 
from the clinical strain used in the present study induced an 
inflammatory response through TLR2-MyD88-dependent, 
but CD14‑independent signaling transduction. There are 
10 TLRs in human cells, each of which can recognize different 
pathogen‑associated molecular patterns (26). LTA is a ligand 
against TLR2 and partially dependent on TLR1, TLR6 and 
CD14 (27). TLR2 may bind easier to E. faecalis LTA than 
other TLRs in infected dental pulps, as an overwhelming 
majority of TLR2-positive macrophages are found in pulp 
inflammation (29).
The interaction of LTA with TLR2-dependent pathways 
can activate intracellular messengers, such as MyD88 and 
MAPKs, and subsequently transcription factors, including 
NF-κB, to stimulate the expression of inflammatory cyto-
kines (28,30). In the present study, the release of cytokines 
was quantified using ELISA and the protein expression of cells 
was assessed using western blot analysis. The dose‑dependent 
increment of TNF-α corresponded to the activation of 
NF-κB at the LTA concentration of 10 µg/ml. NF‑κB is an 
important transcription factor that promotes the rapid release 
of cytokines (31). The present results show that NF‑κB is 
responsible for the production of TNF-α, in terms of the effect 
of the E. faecalis clinical strain LTA on macrophages. The 
p38 was also activated, albeit not simultaneously with NF-κB. 
Martinho et al (16) also reported that the phosphorylation of 
NF-κB and p38 did not reach their peaks at the same time 
in the study of signaling pathways associated with primary 
endodontic infectious contents. In the signaling pathways, the 
upstream adaptors could be responsible for this inconsistent 
phenomenon regarding the activation of NF-κB and p38 (32).
In the present study, highly purified LTA was successfully 
isolated from a clinical E. faecalis strain derived from the 
infected root canal of a patient with persistent apical peri-
odontitis. E. faecalis LTA was also demonstrated to promote 
the expression of pro‑inflammatory cytokine TNF‑α through 
Figure 3. Release of (A) tumor necrosis factor‑α (TNF-α) and (B) interleukin (IL)‑10 was assayed using ELISA. The expression of (C) nuclear factor‑κB (NF-κB) 
and (D) mitogen‑activated protein kinases was assayed using western blot analysis. The band densities of (E) p‑p38, (F) p38, (G) ERK1/2, (H) JNK and (I) p-p65 
were measured using Quantity One 4.6.9 software. Data are presented as mean ± standard deviation. *P<0.05 compared to the untreated cells. LTA, lipoteichoic acid.
WANG et al:  E. faecalis LTA ON MACROPHAGES702
activating the p38 MAPK and NF-κB signaling pathways, but 
did not influence the expression of anti‑inflammatory cytokine 
IL‑10. Therefore, the present study provides a new insight 
into the pathogenic mechanisms of E. faecalis in endodontic 
infections and may possibly lead to the development of novel 
therapeutic options targeting signaling pathways.
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